期刊
CYTOMETRY PART B-CLINICAL CYTOMETRY
卷 96, 期 4, 页码 256-265出版社
WILEY
DOI: 10.1002/cyto.b.21833
关键词
acute lymphoblastic; flow cytometry; immunophenotyping; rare event detection
资金
- BD Biosciences
In this review, we discuss applications of flow cytometric immunophenotyping (FCI) in the diagnostic evaluation and posttreatment monitoring of B and T lymphoblastic leukemia/lymphoma. We describe practical approaches to FCI at the time of diagnosis, with an emphasis on blast identification, lineage assignment, and distinction of B and T lymphoblastic leukemia/lymphoma from their morphologic and immunophenotypic mimics. We further review flow cytometric assays for the detection of minimal or measurable residual disease (MRD) after treatment, and illustrate both standard approaches, and newer strategies for improving sensitivity and circumventing the loss of immunophenotypic targets after immunotherapy. (c) 2019 International Clinical Cytometry Society
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据